Table 3.
Cells used in the experiments on the capacity of the vesicles to act as a potential biomedical therapeutical agent.
| Type of Cells | References |
|---|---|
| Human keratinocyte line (Ha-CaT), human skin fibroblasts (HSFs), human embryonic kidney cells (HEK293T) | [188,198] |
| Fibrotic cell line (LX2), hepatocellular cell line (HEP40) | [189] |
| Cancer cells (MCF-7, HeLa, and N2A), human umbilical vein endothelial cells (HUVEC), primary fibroblasts cells | [191,197] |
| Human colorectal cancer cell line (DLD-1), human neuroblastoma cell line (NB19), human leukemia cell line (K562), ASF-4-1 cells, RD cells | [192] |
| Human alveolar basal epithelial cells (A549) | [182,185] |
| Monocytic U937 cell lines | [185] |
| Human hepatoblastoma cells (HepG2) | [193,194] |
| SMMC-7721 cells, Hep3B cells, normal hepatocyte cell line (LO-2) | [194] |
| Adipose-derived mesenchymal stem cells (ADMSCs) | [88] |
| Human stabilized endothelial cell line (EA.hy926) | [195] |
| Human telomerase immortalized keratinocytes (TIGKs) | [186] |
| Human epithelial colorectal adenocarcinoma cells (Caco-2) | [101,202] |
| Human chronic myeloid leukemia cell line (LAMA84), human colorectal adenocarcinoma cell line (SW480), human bone marrow-derived stromal cell line (HS5) | [182] |
| Human fetal lung fibroblast (MRC-5), human lung adenocarcinoma (A549), human acute monocytic leukemia (THP-1) | [198] |
| KB cells | [199] |
| Mouse hippocampal neuronal cells (HT22) | [190] |
| Mouse C57BL/6 lung carcinoma cells (LLC1), monkey kidney Vero E6 cell | [185] |
| Mouse bone marrow-derived macrophages (BMDMs) | [196] |
| C57BL/6 murine colon adenocarcinoma cells (MC-38) | [101] |
| Murine RAW 264.7 cells | [200] |